These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37107208)

  • 21. Impact of Physical Activity Differences Due to COVID-19 Pandemic Lockdown on Non-Alcoholic Fatty Liver Parameters in Adults with Metabolic Syndrome.
    Mascaró CM; Bouzas C; Montemayor S; García S; Mateos D; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
    Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study.
    Entezari MR; Talenezhad N; Mirzavandi F; Rahimpour S; Mozaffari-Khosravi H; Fallahzadeh H; Hosseinzadeh M
    J Nutr Sci; 2021; 10():e55. PubMed ID: 34367629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial.
    Cantero I; Abete I; Babio N; Arós F; Corella D; Estruch R; Fitó M; Hebert JR; Martínez-González MÁ; Pintó X; Portillo MP; Ruiz-Canela M; Shivappa N; Wärnberg J; Gómez-Gracia E; Tur JA; Salas-Salvadó J; Zulet MA; Martínez JA
    Clin Nutr; 2018 Oct; 37(5):1736-1743. PubMed ID: 28734553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
    Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
    Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease.
    Javadi L; Khoshbaten M; Safaiyan A; Ghavami M; Abbasi MM; Gargari BP
    Asia Pac J Clin Nutr; 2018; 27(5):1031-1039. PubMed ID: 30272851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Stages of Hepatic Steatosis and Physical Activity Performance in Adults with Metabolic Syndrome: A Cross-Sectional Analysis in FLIPAN Study.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory and Oxidative Stress Markers Related to Adherence to the Mediterranean Diet in Patients with Metabolic Syndrome.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; Gómez C; Mateos D; Ripoll-Vera T; Tur JA; Sureda A
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease.
    Baratta F; Pastori D; Bartimoccia S; Cammisotto V; Cocomello N; Colantoni A; Nocella C; Carnevale R; Ferro D; Angelico F; Violi F; Del Ben M
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32531941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
    Pour FK; Aryaeian N; Mokhtare M; Mirnasrollahi Parsa RS; Jannani L; Agah S; Fallah S; Moradi N
    Phytother Res; 2020 Dec; 34(12):3367-3378. PubMed ID: 32798261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity.
    Kenđel Jovanović G; Mrakovcic-Sutic I; Pavičić Žeželj S; Benjak Horvat I; Šuša L; Rahelić D; Klobučar Majanović S
    Can J Gastroenterol Hepatol; 2021; 2021():6649142. PubMed ID: 33628758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Rafie R; Hosseini SA; Hajiani E; Saki Malehi A; Mard SA
    Clin Exp Gastroenterol; 2020; 13():35-45. PubMed ID: 32158249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
    Trovato FM; Catalano D; Martines GF; Pace P; Trovato GM
    Clin Nutr; 2015 Feb; 34(1):86-8. PubMed ID: 24529325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
    Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
    Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.